Article List

WPRIM Management System> DCMS> Journal of Breast Cancer> 2009> 12> 4

Volume: 12 Issue: 4

1. Angiolipoma of the Breast: A Case Report.	Page:344—346
2. Experience with Intracystic Papillary Carcinoma of the Breast at a Single Institute in Korea.	Page:338—343
3. Changes in the Hormone Receptors and the HER2 Expression in Primary and Recurrent Breast Cancer.	Page:331—337
4. Factors Affecting the Ipsilateral Breast Tumor Recurrence after Breast Conserving Therapy in Patients with T1 and T2 Tumors.	Page:324—330
5. The Influence of Breast Volume on Prognosis of Primary Breast Cancer with Same T Stage.	Page:316—323
6. The Clinical Significance of Diffuse Thyroid Uptake That is Incidentally Identified by F-18 FDG PET/CT Imaging in Patients with Breast Cancer.	Page:309—315
7. Risk Factors of Local Recurrence after Breast Conserving Therapy in Invasive Breast Cancer.	Page:302—308
8. The Comparison of Automated Silver in situ Hybridization and Fluorescence in situ Hybridization for Evaluating HER2 Gene Amplification in Breast Carcinoma.	Page:295—301
9. The Prognostic Significance of Survivin Expression in Breast Cancer.	Page:285—294
10. Phase II Study of Vinorelbine Plus Ifosfamide in Patients with Taxane-resistant Metastatic Breast Cancer.	Page:278—284
11. Arm Sentinel Lymph Node Detection for Preserving the Arm Lymphatic System.	Page:272—277
12. A Comparison of Outcomes for the Patients with Pathologically Node-negative Breast Cancer and Who Were Treated Either with Sentinel Lymph Node Biopsy Only or with Conventional Axillary Lymph Node Dissection.	Page:265—271
13. Validation of Radiation Volume by Analysis of Recurrence Pattern in Breast-conserving Treatment for Early Breast Cancer.	Page:257—264
14. Expression of CXCR4 and SDF-1alpha in Primary Breast Cancers and Metastatic Lymph Nodes.	Page:249—256
15. Comparison between Therapeutic Efficacies of Histone Deacetylase Inhibitors and Established Drug Regimens Against Breast Cancer Cells using the Histoculture Drug Response Assay.	Page:241—248
16. Comparison of Silver-Enhanced in situ Hybridization and Fluorescence in situ Hybridization for HER2 Gene Status in Breast Carcinomas.	Page:235—240
17. Molecular Targets for Treatment of Breast Cancer.	Page:229—234